4DMedical Limited (FDMDF)

Market Cap	2.48B +2,504.4%
Revenue (ttm)	3.88M -0.8%
Net Income	-115.35M
EPS	-0.28
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	174
Average Volume	29,987
Open	3.160
Previous Close	3.330
Day's Range	3.160 - 3.160
52-Week Range	0.163 - 3.330
Beta	2.82
RSI	65.30
Earnings Date	Feb 27, 2026

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of poten...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 124
• Stock Exchange: OTCMKTS
• Ticker Symbol: FDMDF

Financial Performance

In fiscal year 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.

Financial numbers in AUD